SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-13-088640
Filing Date
2013-12-05
Accepted
2013-12-05 16:52:34
Documents
1
Period of Report
2013-11-26

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 2744
  Complete submission text file 0001104659-13-088640.txt   4148
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0020
ContraVir Pharmaceuticals, Inc. (Issuer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CONTRAVIR PHARMACEUTICALS, INC. 420 LEXINGTON AVENUE, SUITE 2012 NEW YORK NY 10170
Business Address
Block Timothy M. (Reporting) CIK: 0001593465 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55020 | Film No.: 131260327